ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,897Medicare Part D Prescriptions Filled, Including Refills

Rank: 77 out of 1024

$654K Total Retail Price of All Prescriptions

Rank: 143 out of 1024

432 Patients Receiving at Least One Drug in Part D
94% Patients 65 Years and Older
66% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Connecticut
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

12% of this provider’s 432 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

5% of this provider’s 432 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $68 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Connecticut
WARFARIN SODIUM 599 599 39 1 8
FUROSEMIDE 479 467 61 2 6
AMLODIPINE BESYLATE 453 448* 83 3 3
ATORVASTATIN CALCIUM 415 378 83 4 1
LEVOTHYROXINE SODIUM 347 322 73 5 2
METOPROLOL TARTRATE 345 345 70 6 7
NAMENDA 342 342 28 7 27
LISINOPRIL 322 295 66 8 4
OMEPRAZOLE 297 292* 71 9 9
SIMVASTATIN 260 238 55 10 5
TRAZODONE HCL 237 224 45 11 22
SERTRALINE HCL 235 200 34 12 23
DONEPEZIL HCL 223 218* 33 13 25
ESCITALOPRAM OXALATE 215 210* 32 14 14
METOPROLOL SUCCINATE 197 170 38 15 12
MIRTAZAPINE 193 182 30 16 31
LORAZEPAM 190 185* 44 B 17 26
DIOVAN 167 167 15 18 21
HYDROCHLOROTHIAZIDE 165 148 24 19 11
ATENOLOL 145 145 28 20 13
CYMBALTA 142 137* 12 21 35
METFORMIN HCL 142 131 23 21 10
CITALOPRAM HBR 137 125 19 23 37
DIVALPROEX SODIUM 133 115 16 24 59
EVISTA 126 <11 <11 25 159
GABAPENTIN 125 112 24 26 18
NEXIUM 124 91 16 27 33
PREDNISONE 117 117 41 28 38
CLOPIDOGREL 113 102 21 29 28
TRAMADOL HCL 104 104 21 30 36
CARBIDOPA-LEVODOPA 101 101 14 31 92
GLIMEPIRIDE 98 93* 15 32 54
POTASSIUM CHLORIDE 95 95 12 33 30
TAMSULOSIN HCL 92 92 28 34 24
LANTUS 91 72 14 35 53
QUETIAPINE FUMARATE 91 86* 16 A 35 44
ABILIFY 89 <11 <11 A 37 77
LOSARTAN POTASSIUM 88 88 17 38 16
LEVETIRACETAM 85 <11 <11 39 75
ALLOPURINOL 76 64 16 40 34
CLOZAPINE 72 <11 <11 A 41 104
IPRATROPIUM-ALBUTEROL 70 70 37 42 80
RISPERIDONE 68 63* 12 A 43 48
KLOR-CON M20 67 67 21 44 70
ZOLPIDEM TARTRATE 64 59* 16 45 19
OXYBUTYNIN CHLORIDE ER 63 63 12 46 93
ALENDRONATE SODIUM 62 <11 <11 47 39
ZETIA 62 <11 <11 47 52
PANTOPRAZOLE SODIUM 61 56* 12 49 29
FLUOXETINE HCL 60 <11 <11 50 88
AMIODARONE HCL 59 <11 <11 51 171
TOPIRAMATE 58 <11 <11 52 160
OXYCODONE HCL 56 56 23 S2 53 55
ALPRAZOLAM 55 55 14 B 54 17
DILTIAZEM 24HR CD 55 50* 13 54 110
OXYCODONE-ACETAMINOPHEN 54 54 16 S2 56 61
OLANZAPINE 52 <11 <11 A 57 73
NOVOLOG 52 35 11 57 101
JANUVIA 50 <11 <11 59 45
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.